Life Science Platform Delivers Real Time, Comprehensive and Seamless Public and Proprietary Biological Sequence, Interaction and Patent Information
PHILADELPHIA, Sept. 10 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, announced today the release of BONDplus, an integrated, web-based data platform to address the information and analytic needs of biological researchers.
Compiled from 15 assembled resources including GenBank, RefSeq, Entrez Gene and UniProtKB/Swiss-Prot, BONDplus allows researchers to move beyond the genome and leverage publicly available biological sequence data, BINDplus biomolecular interaction data as well as GENESEQ, a value added database of patented biological sequences. The platform allows novel insights into biological research including target-based discovery and rational drug design.
"Today's life science data management faces considerable hurdles due to years of fragmented and non-standardized production of biological data," said Jon Brett-Harris, executive vice president of pharmaceutical and chemical markets at Thomson Scientific. "Since solutions are frequently focused on one data type or in a niche area, an integrated platform can provide a distinct competitive advantage, allowing scientists not only to access public domain data, but also to integrate their own proprietary data and value-added Thomson Scientific data in a consistent and user-friendly format."
BONDplus provides an intuitive and value-added resource for any researcher by uniting the genomic, proteomic and metabolomic research communities around one comprehensive platform. The subscription service provides information from over 15 assembled resources including BINDplus and GENESEQ in addition to pre- computed data sets with BLAST functionality, visualization tools and over 80 million in public domain sequences.
A leading provider of life science research information, Thomson serves primary, secondary and tertiary data types, ranging from proteins and small molecules to gene and protein expression and more complex data types such as toxicology/efficacy data, biomarker, interaction and pathway information.
For more information on BONDplus, please visit: http://scientific.thomson.com/bondplus/
About The Thomson Corporation
The Thomson Corporation (http://www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development-from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.
|SOURCE Thomson Scientific|
Copyright©2007 PR Newswire.
All rights reserved